These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 33007268)
21. Cancer stem-like cells with hybrid epithelial/mesenchymal phenotype leading the collective invasion. Quan Q; Wang X; Lu C; Ma W; Wang Y; Xia G; Wang C; Yang G Cancer Sci; 2020 Feb; 111(2):467-476. PubMed ID: 31845453 [TBL] [Abstract][Full Text] [Related]
22. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307 [TBL] [Abstract][Full Text] [Related]
23. EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer. Liu X; Adorno-Cruz V; Chang YF; Jia Y; Kawaguchi M; Dashzeveg NK; Taftaf R; Ramos EK; Schuster EJ; El-Shennawy L; Patel D; Zhang Y; Cristofanilli M; Liu H Theranostics; 2021; 11(13):6632-6643. PubMed ID: 33995681 [TBL] [Abstract][Full Text] [Related]
25. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis. Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317 [TBL] [Abstract][Full Text] [Related]
26. Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling. Zhang H; Meng F; Wu S; Kreike B; Sethi S; Chen W; Miller FR; Wu G Cancer Res; 2011 Jul; 71(14):4846-56. PubMed ID: 21750175 [TBL] [Abstract][Full Text] [Related]
27. β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer. Truong HH; Xiong J; Ghotra VP; Nirmala E; Haazen L; Le Dévédec SE; Balcioğlu HE; He S; Snaar-Jagalska BE; Vreugdenhil E; Meerman JH; van de Water B; Danen EH Sci Signal; 2014 Feb; 7(312):ra15. PubMed ID: 24518294 [TBL] [Abstract][Full Text] [Related]
28. ΔNp63 activates EGFR signaling to induce loss of adhesion in triple-negative basal-like breast cancer cells. Holcakova J; Nekulova M; Orzol P; Nenutil R; Podhorec J; Svoboda M; Dvorakova P; Pjechova M; Hernychova L; Vojtesek B; Coates PJ Breast Cancer Res Treat; 2017 Jun; 163(3):475-484. PubMed ID: 28349272 [TBL] [Abstract][Full Text] [Related]
29. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics. Chen W; Allen SG; Reka AK; Qian W; Han S; Zhao J; Bao L; Keshamouni VG; Merajver SD; Fu J BMC Cancer; 2016 Aug; 16():614. PubMed ID: 27501846 [TBL] [Abstract][Full Text] [Related]
30. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis. Shriver M; Stroka KM; Vitolo MI; Martin S; Huso DL; Konstantopoulos K; Kontrogianni-Konstantopoulos A Oncogene; 2015 Aug; 34(32):4248-59. PubMed ID: 25381817 [TBL] [Abstract][Full Text] [Related]
31. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin. Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639 [TBL] [Abstract][Full Text] [Related]
32. Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin. Grasset EM; Dunworth M; Sharma G; Loth M; Tandurella J; Cimino-Mathews A; Gentz M; Bracht S; Haynes M; Fertig EJ; Ewald AJ Sci Transl Med; 2022 Aug; 14(656):eabn7571. PubMed ID: 35921474 [TBL] [Abstract][Full Text] [Related]
33. MiR-1976 knockdown promotes epithelial-mesenchymal transition and cancer stem cell properties inducing triple-negative breast cancer metastasis. Wang J; Li M; Han X; Wang H; Wang X; Ma G; Xia T; Wang S Cell Death Dis; 2020 Jul; 11(7):500. PubMed ID: 32620748 [TBL] [Abstract][Full Text] [Related]
34. The pro-metastasis effect of circANKS1B in breast cancer. Zeng K; He B; Yang BB; Xu T; Chen X; Xu M; Liu X; Sun H; Pan Y; Wang S Mol Cancer; 2018 Nov; 17(1):160. PubMed ID: 30454010 [TBL] [Abstract][Full Text] [Related]
35. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer. Ring A; Kaur P; Lang JE BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919 [TBL] [Abstract][Full Text] [Related]
36. CD155 contributes to the mesenchymal phenotype of triple-negative breast cancer. Zheng Q; Gao J; Yin P; Wang W; Wang B; Li Y; Zhao C Cancer Sci; 2020 Feb; 111(2):383-394. PubMed ID: 31830330 [TBL] [Abstract][Full Text] [Related]
38. Suspension state promotes metastasis of breast cancer cells by up-regulating cyclooxygenase-2. Zhang X; Yang L; Chien S; Lv Y Theranostics; 2018; 8(14):3722-3736. PubMed ID: 30083255 [TBL] [Abstract][Full Text] [Related]
39. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition. Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283 [TBL] [Abstract][Full Text] [Related]
40. FGF13 promotes metastasis of triple-negative breast cancer. Johnstone CN; Pattison AD; Harrison PF; Powell DR; Lock P; Ernst M; Anderson RL; Beilharz TH Int J Cancer; 2020 Jul; 147(1):230-243. PubMed ID: 31957002 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]